Literature DB >> 6337669

Randomized controlled trial of injection sclerotherapy for bleeding oesophageal varices--an interim report.

Y M Yassin, S M Sherif.   

Abstract

Oesophageal varices are the commonest cause of acute upper gastrointestinal bleeding in Egypt, due to the prevalence not only of schistosomiasis but also chronic hepatitis. Poor results of conventional treatment and shunt surgery led us to evaluate injection sclerotherapy, using fibreoptic endoscopy. In a controlled trial, 108 patients were randomly allocated to injection sclerotherapy or to conventional treatment (medical measures, with modified splenectomy and oesophagogastric devascularization in selected cases). We report the results in the first 108 patients, with a follow-up of 1-35 months. Fifty-three patients received injection sclerotherapy; 5 died (2 of recurrent bleeding) and 5 others had recurrent bleeding but were controlled by further injections. Thirty-six of the 55 control patients underwent surgery; 5 died (2 of recurrent bleeding) and 2 others developed recurrent bleeding. Further bleeding occurred in 12 of the 19 patients who were managed by medical measures alone, with 7 dying. These early results indicate that injection sclerotherapy can be effective in urgent and elective situations and that it appears to have advantages over conventional medical and surgical treatments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337669     DOI: 10.1002/bjs.1800700107

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  The management of an episode of variceal bleeding.

Authors:  A E Gimson; D Westaby
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Hepatosplenic schistosomiasis: a clinical review.

Authors:  K M De Cock
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

3.  Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.

Authors:  S S Elsayed; G Shiha; M Hamid; F M Farag; F Azzam; M Awad
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

Review 4.  Sclerotherapy for bleeding esophageal varices after randomized trials.

Authors:  D A Lieberman
Journal:  West J Med       Date:  1986-10

Review 5.  Acute management of bleeding oesophageal varices.

Authors:  A K Burroughs
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 6.  Complications and limitations of injection sclerotherapy in portal hypertension.

Authors:  N D Heaton; E R Howard
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

7.  Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial.

Authors:  W D Warren; J M Henderson; W J Millikan; J T Galambos; W S Brooks; S P Riepe; A A Salam; M H Kutner
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

8.  Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Danielle Roberts; Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Sivapatham Arunan; Tanjia Begum; Norman R Williams; Dana Walshaw; Elisabeth Jane Milne; Maxine Tapp; Mario Csenar; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-10

9.  Endoscopic injection sclerotherapy in patients with bleeding esophageal varices: a retrospective analysis.

Authors:  J B Chung; D K Nam; K H Han; W H Kim; D Y Kim; C Y Chon; S I Lee; J K Kang; I S Park; H J Choi
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.